The Zoster Vaccine Rapidly Loses Effectiveness in Adults Over 60.

The Zoster Vaccine Rapidly Loses Effectiveness in Adults Over 60.

Watkins Richard R

Infectious Disease Alert

2016

2016-07

The article reports that the Herpes Zoster (HZ) vaccine has decreased its effectiveness in adults that are above 60 years of age. Topics discussed include decline in beneficial effect of the HZ vaccine; determination of an optimal re-dosing strategy to make the vaccine more effective; and decline in the effectiveness of the vaccine in preventing PHN.

Adult; Aged; Incidence; Age Factors; Human; Middle Age; Immunization; Quality-Adjusted Life Years; Nonexperimental Studies; Cost Benefit Analysis; Herpes Zoster Vaccine; Neuralgia; Herpes Zoster – Prevention and Control; Herpes Zoster Vaccine – In Old Age; Postherpetic

Article information provided for research and reference use only. All rights are retained by the journal listed under publisher and/or the creator(s).

111–112

10

35